Corrigendum to “Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables” [Int. J. Mycobacteriol. 5(1) 2016 1-6]. Go to Publication You Might Also Like Evaluation of light emitting diode-based fluorescence microscopy for the detection of mycobacteria in a tuberculosis-endemic region. April 10, 2011 Safety and efficacy of thioridazine as salvage therapy in Indian patients with XDR-TB. May 3, 2011 Increasing incidence of fluoroquinolone-resistant Mycobacterium tuberculosis in Mumbai, India. January 31, 2009 Management of interstitial lung diseases: A consensus statement of the Indian Chest Society (ICS) and National College of Chest Physicians (NCCP) September 3, 2020 Drug-resistant tuberculosis in India. November 6, 2002
Evaluation of light emitting diode-based fluorescence microscopy for the detection of mycobacteria in a tuberculosis-endemic region. April 10, 2011
Increasing incidence of fluoroquinolone-resistant Mycobacterium tuberculosis in Mumbai, India. January 31, 2009
Management of interstitial lung diseases: A consensus statement of the Indian Chest Society (ICS) and National College of Chest Physicians (NCCP) September 3, 2020